Federated Hermes, Inc. Stoke Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.78 - $11.99 $4,067 - $12,901	1,076 New	1,076 $4,000
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $1.88 Million - $4.33 Million	181,014 Added 264.83%	249,364 $3.29 Million
Q1 2022 May 13, 2022	SELL	$17.19 - $26.1 $11.5 Million - $17.4 Million	-666,485 Reduced 90.7%	68,350 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $851 - $1,443	-47 Reduced 0.01%	734,835 $17.6 Million
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $2.77 Million - $4.03 Million	-116,993 Reduced 13.73%	734,882 $18.7 Million
Q2 2021 Aug 16, 2021	SELL	$30.53 - $41.09 $622,476 - $837,784	-20,389 Reduced 2.34%	851,875 $28.7 Million
Q1 2021 May 13, 2021	SELL	$36.08 - $69.81 $3.48 Million - $6.74 Million	-96,547 Reduced 9.97%	872,264 $33.9 Million
Q4 2020 Feb 12, 2021	BUY	$33.62 - $61.93 $4.65 Million - $8.57 Million	138,411 Added 16.67%	968,811 $60 Million
Q1 2020 May 13, 2020	BUY	$16.8 - $34.15 $957,314 - $1.95 Million	56,983 Added 7.37%	830,400 $19 Million
Q4 2019 Feb 14, 2020	BUY	$20.01 - $30.79 $3.95 Million - $6.08 Million	197,417 Added 34.27%	773,417 $21.9 Million
Q3 2019 Nov 14, 2019	BUY	$20.53 - $37.72 $9.46 Million - $17.4 Million	461,000 Added 400.87%	576,000 $12.4 Million
Q2 2019 Aug 14, 2019	BUY	$25.53 - $29.17 $2.94 Million - $3.35 Million	115,000 New	115,000 $3.36 Million

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.